Association Between Smoking and Chronic Rhinosinusitis: A Systematic Review and Meta‐Analysis

Abstract

ObjectiveChronic rhinosinusitis (CRS) is a prevalent inflammatory disease of the upper airway. The impact of smoking on CRS has not been clearly established. We aim to clarify the association between first‐hand cigarette smoking and the prevalence and prognoses of CRS.Review MethodsPubMed, Embase, SCOPUS, and Cochrane Library were searched from inception until May 15, 2022. Three blinded reviewers selected relevant studies, extracted data, and evaluated study bias following a PROSPERO‐registered protocol (CRD42022345585). We used random‐effects meta‐analyses to pool the prevalence of smoking in CRS, association between smoking status and CRS, and association of smoking with quality of life (QOL) before and after functional endoscopic sinus surgery (FESS). We also performed descriptive analyses of olfactory function, CT scores, and endoscopy scores before and after FESS.ResultsWe included 23 cross‐sectional studies, 19 cohort studies, two case–control studies, and one prospective clinical trial. The pooled prevalence of ever‐smokers was 40% (95% CI = 0.30–0.51) and 33% (95% CI = 0.25–0.43) in patients with and without CRS. Compared to never‐smokers, active smokers and past smokers had 1.35 (95% CI = 1.18–1.55) and 1.23 (95% CI = 1.17–1.29) higher odds of having CRS. Among patients with CRS, non‐smokers reported higher initial QOL than smokers (standardized mean difference [SMD] = 0.23, 95% CI = 0.11–0.35), although post‐FESS QOL was similar (SMD = 0.10, 95% CI = −0.30–0.51). Descriptive analysis found no significant correlations between smoking and post‐FESS olfactory function and endoscopy scores.ConclusionsCigarette smoking is associated with higher prevalence and odds of CRS. Clinicians should be aware that smoking predisposes to CRS, but does not negatively impact the rhinologic outcomes of FESS. Laryngoscope, 2023